DNA Script in the news
Enzymatic DNA synthesis technology
Tamtam found 20 recent articles about DNA Script.
- The Power of Enzymatic DNA Synthesis
Enzymatic DNA synthesis enables rapid, benchtop DNA printing that accelerates research, vaccine development, and personalized therapies by reducing delays and increasing accessibility.
- DNA Data Storage-as-a-Service Market Is Going to Boom | Illumina, GenScript, DNA Script, Helixworks
The DNA Data Storage-as-a-Service market is rapidly growing due to advances in DNA synthesis and sequencing, offering ultra-dense, long-term data storage solutions primarily in North America and Europe.
- DNA Synthesizer Market Top Players - LGC Limited; CSBio; K&A Labs GmbH; DNA Script; OligoMaker ApS.
The DNA synthesizer market is rapidly growing due to technological advances and expanding applications in healthcare and biotechnology, with DNA Script among key players.
- Made-to-order DNA goes big: new tech doubles size of custom genetic sequences
New enzymatic DNA synthesis technologies double the length of custom DNA sequences and simplify benchtop synthesis, overcoming limitations of traditional chemical methods.
- Unlocking the Unattainable in Gene Construction
Webinar by DNA Script highlights enzymatic DNA synthesis to advance gene construction in biotechnology.
- Accelerating mRNA Vaccine Production
CEPI and DNA Script are accelerating mRNA vaccine production by developing rapid, automated synthetic DNA template technology to reduce costs and improve global access.
- Quantoom, DNA Script and EVA Pharma unite on Africa mRNA project
Quantoom, DNA Script, and EVA Pharma collaborate to develop an mRNA vaccine production platform to boost Africa's local vaccine manufacturing capacity and meet regional immunization goals.
- Africa Aims for Vaccine Independence with New Partnership
EVA Pharma, DNA Script, and Quantoom Biosciences collaborate to create an integrated mRNA vaccine production platform to boost Africa’s local vaccine manufacturing capacity.
- Pushing mRNA vaccine development timelines to new speeds
CEPI funds DNA Script to accelerate synthetic DNA template production for mRNA vaccines, aiming to cut development times and improve global vaccine access.
- DNA Script Breaks Length and Complexity Barriers With New Enzymatic DNA Synthesis Offering
DNA Script's new enzymatic DNA synthesis technology enables production of complex custom DNA sequences up to 500 nucleotides, surpassing traditional chemical synthesis limits.
- Marc Montserrat prend la direction générale de DNA Script - Ressources humaines - Actionco.fr
Marc Montserrat, with extensive biotech experience, is named CEO of DNA Script to lead its commercial strategy.
- Marc Montserrat prend la direction générale de DNA Script
Marc Montserrat, with over 20 years in biotech, is named CEO of DNA Script to lead its commercial strategy.
- DNA Scritp
DNA Script has launched a US subsidiary, expanded its leadership, and reached key milestones in enzymatic DNA synthesis technology with plans to commercialize products soon.
- DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform
DNA Script appoints Marc Montserrat as CEO to drive commercial growth while founder Thomas Ybert shifts to Chief Scientific Officer to focus on innovation in enzymatic DNA synthesis.
- DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform
DNA Script appointed Marc Montserrat as CEO to drive commercial growth while founder Thomas Ybert focuses on scientific innovation in enzymatic DNA synthesis.
- Changement de patron, licenciements : la biotech DNA Script en zone de turbulences
DNA Script is undergoing leadership changes with CEO Thomas Ybert stepping down to focus on scientific direction, as the company seeks new strategies and a new CEO.
- Le PDG de DNA Script passe la main
DNA Script's CEO Thomas Ybert is stepping down at the executive committee's request amid financial difficulties.
- DNA Script : pourquoi la start-up star de la biotech française tombe de haut
DNA Script is experiencing internal and financial difficulties, delaying its 2023 accounts approval and casting doubt on its future.
- Enzymatic DNA Synthesis: Shorter Waits, Longer Strands
Enzymatic DNA synthesis technologies are advancing rapidly, enabling faster, longer, and more accurate DNA production for diverse biotech applications beyond the limits of traditional chemical methods.
- Enzymatic DNA Synthesis: Going to Great Lengths
Enzymatic DNA synthesis using TdT is advancing to produce longer, more accurate DNA strands than chemical methods, with companies like Ansa Biotechnologies and DNA Script leading innovations.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like DNA Script?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies